Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.20
-0.08 (-1.61%)
May 28, 2026, 12:41 PM EDT - Market open
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $9.99 million as of May 28, 2026. Its market cap has decreased by -29.56% in one year.
Market Cap
9.99M
Enterprise Value
9.57M
1-Year Change
-29.56%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $9.99M, a decrease of -98.55%. That is a compound annual growth rate of -54.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 10.16M | -3.24% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 11.16M |
| Kairos Pharma | 11.07M |
| BioRestorative Therapies | 11.03M |
| Aprea Therapeutics | 10.96M |
| Jupiter Neurosciences | 10.42M |
| Immuron | 10.26M |
| BioCardia | 10.24M |
| Psyence Biomedical | 9.91M |